In summary, we are making significant strides in advancing BOT/BAL and positioning Agenus for long-term success. I'll now ...

Adjusted EBITDA -- $1.1 million for the period, compared to an adjusted loss of $1.4 million in the same quarter last year.

Beena Wood, Qinecsa, explains how AI could revolutionize pharmacovigilance, if data, trust, skills, and organizational ...

This is an audio transcript of the Unhedged podcast episode: ‘ Outlook 2026’ ...

Marc Filippino Good morning from the Financial Times. Today is Friday, January 9th, and this is your FT News Briefing. It ...

Beena Wood, Qinecsa, outlines how proactive PV, translational safety, AI foundations, and ecosystem collaboration will ...

Outstanding Shares and Warrants -- 12.2 million shares, 852,000 warrants (including 167,000 at $2.85 expiring May 2026 and ...

Q2 2026 Earnings Call Transcript January 8, 2026 RPM International Inc. misses on earnings expectations. Reported EPS is $1.2 ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Q1 2026 Earnings Call Transcript January 8, 2026 Acuity Brands, Inc. beats earnings expectations. Reported EPS is $4.69, ...

Its an odd predicament for a leading Democratic presidential contender. Gavin Newsoms biggest strength - political spin and ...